We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$3.41B
AUM Growth
-$160M
Cap. Flow
-$259M
Cap. Flow %
-7.61%
Top 10 Hldgs %
34.8%
Holding
347
New
63
Increased
121
Reduced
48
Closed
53

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$35.4M
2
ULTA icon
Ulta Beauty
ULTA
+$27.5M
3
AMD icon
Advanced Micro Devices
AMD
+$23.5M
4
AMZN icon
Amazon
AMZN
+$18.7M
5
BKNG icon
Booking.com
BKNG
+$17.6M

Top Sells

Rank Stock Value
1
CARK icon
CastleArk Large Growth ETF
CARK
+$322M
2
NFLX icon
Netflix
NFLX
+$65.9M
3
LRCX icon
Lam Research
LRCX
+$20.4M
4
DXCM icon
DexCom
DXCM
+$20.2M
5
META icon
Meta Platforms (Facebook)
META
+$16.7M

Sector Composition

Rank Sector Weight
1 Technology 33.87%
2 Industrials 11.15%
3 Financials 10.44%
4 Consumer Discretionary 10.16%
5 Healthcare 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
301
Boston Scientific
BSX
$67.6B
– –
-2,350
Closed -$229K
CARK icon
302
CastleArk Large Growth ETF
CARK
$314M
– –
-7,383,950
Closed -$322M
CORT icon
303
Corcept Therapeutics
CORT
$9.78B
– –
-2,740
Closed -$228K
CORZ icon
304
Core Scientific
CORZ
$6.59B
– –
-94,131
Closed -$1.69M
CVX icon
305
Chevron
CVX
$378B
– –
-3,170
Closed -$492K
DAVE icon
306
Dave Inc
DAVE
$5.16B
– –
-9,863
Closed -$1.97M
DE icon
307
Deere & Co
DE
$169B
– –
-4,620
Closed -$2.11M
DXCM icon
308
DexCom
DXCM
$28.3B
– –
-300,249
Closed -$20.2M
ENVX icon
309
Enovix
ENVX
$923M
– –
-168,590
Closed -$1.68M
FANG icon
310
Diamondback Energy
FANG
$55.1B
– –
-11,855
Closed -$1.7M
HIMS icon
311
Hims & Hers Health
HIMS
$7B
– –
-43,494
Closed -$2.47M
HOLX
312
DELISTED
Hologic
HOLX
– –
-8,790
Closed -$593K
HSBC icon
313
HSBC
HSBC
$357B
– –
-42,100
Closed -$2.99M
IAI icon
314
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.38B
– –
-19,520
Closed -$3.45M
ITRI icon
315
Itron
ITRI
$3.76B
– –
-42,070
Closed -$5.24M
KFY icon
316
Korn Ferry
KFY
$4.13B
– –
-77,641
Closed -$5.43M
KNF icon
317
Knife River
KNF
$4.46B
– –
-51,539
Closed -$3.96M
MANH icon
318
Manhattan Associates
MANH
$9.42B
– –
-2,350
Closed -$482K
MCD icon
319
McDonald's
MCD
$192B
– –
-10,250
Closed -$3.11M
MGNI icon
320
Magnite
MGNI
$2.73B
– –
-193,185
Closed -$4.21M
MPC icon
321
Marathon Petroleum
MPC
$91.2B
– –
-46,258
Closed -$8.92M
NFLX icon
322
Netflix
NFLX
$293B
– –
-549,480
Closed -$65.9M
ORCL icon
323
Oracle
ORCL
$345B
– –
-51,200
Closed -$14.4M
PLUG icon
324
Plug Power
PLUG
$2.87B
– –
-728,110
Closed -$1.7M
PM icon
325
Philip Morris
PM
$305B
– –
-49,855
Closed -$8.09M
10 11 12
13
14

Similar funds

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
JIC
Joel Isaacson & Co New York $3.02B AUM 21.81% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return
Members Trust
Members Trust Tampa, Florida $3.01B AUM 10.24% 1-Year Est. Return
BGDI
BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return

Castleark Management's Q4 2025 Portfolio in Review

As of Q4 2025, Castleark Management held 347 positions worth $3.41B, down 4.5% from $3.57B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Castleark Management withdrew a net $259M in Q4 2025, closing 53 positions and reducing 48 holdings. Its most notable exit was CastleArk Large Growth ETF, an estimated $322M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Financials.

Against the trend, Castleark Management opened a new position in Ulta Beauty worth $30.2M.

  • Castleark Management's largest Q4 2025 buy was Ulta Beauty: 49,941 shares worth $30.2M.
  • Castleark Management added most to Eli Lilly in Q4 2025, an estimated $35.4M increase.
  • Castleark Management's biggest Q4 2025 reduction was Lam Research, cutting an estimated $20.4M.
  • Castleark Management fully exited CastleArk Large Growth ETF in Q4 2025, selling an estimated $322M.
  • Castleark Management's ten largest holdings make up 35% of its $3.41B portfolio in Q4 2025.
  • Castleark Management opened 63 new positions and closed 53 in Q4 2025.
  • Castleark Management's portfolio value fell 4.5% quarter-over-quarter to $3.41B.

Based on Castleark Management's 13F filing for Q4 2025, filed 13 Feb 2026.